Posted on September 16, 2021September 16, 2021SysAdminUncategorizedLaunch of Gunze’s U.S. Medical Division WebsiteRead More
Posted on September 24, 2020June 9, 2021SysAdminUncategorizedGunze provides biodegradable scaffolds for TEVG clinical trial to be conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to improve pediatric patient clinical outcomeRead More
Posted on September 24, 2020May 3, 2022SysAdminUncategorizedGunze Enters into Exclusive Supply and Distribution Agreement with Misonix for TheraGenesis® Bilayer Wound Matrix in U.S. MarketRead More
Posted on April 29, 2020May 3, 2022SysAdminUncategorizedPELNAC® Bilayer Wound Matrix Receives U.S. Food and Drug Administration (FDA) ClearanceRead More
